Viridian Therapeutics, Inc. (VRDN)
17.24
-0.45
(-2.54%)
USD |
NASDAQ |
May 22, 16:00
17.22
-0.02
(-0.12%)
After-Hours: 20:00
Viridian Therapeutics Market Cap : 1.904B for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 183.12B |
| Plus Therapeutics, Inc. | 45.22M |
| Perspective Therapeutics, Inc. | 453.90M |
| AVITA Medical, Inc. | 140.96M |
| Twist Bioscience Corp. | 3.772B |
Market Cap Related Metrics
| PS Ratio | 21.88 |
| Price to Book Value | 3.778 |
| Price | 17.24 |
| Earnings Yield | -21.84% |